Cell Therapy

Top Story

Will CAR T cells become first-line therapy for hematologic malignancies?

Will CAR T cells become first-line therapy for hematologic malignancies?
HemOnc Today, March 25, 2019
Cover Story

New indications may accelerate ‘explosion’ in CAR T-cell therapy, but more education still needed

HemOnc Today, March 25, 2019
Years of research into chimeric antigen receptor T-cell therapy for cancer treatment is finally paying dividends. When Renier J. Brentjens, MD, PhD, director of…
Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed diffuse large…

CAR T-cell therapy changing the landscape of lymphoma treatment

March 23, 2019
NEW YORK — Chimeric antigen receptor T cell therapies could be the breakthrough hematologists have sought to effectively treat certain patients with lymphoma…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: Take homes from GI Outlook: Leadership, MACRA, burnout

August 20, 2018
More »
CME ABIM MOC

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »